G
Glenn D. Newport Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
High Impact
Researcher
faculty
31 h-index
86 pubs
4,249 cited
Research Areas
Biography and Research Information
OverviewAI-generated summary
Glenn D. Newport is a researcher with a focus on the neurotoxicological effects of various substances, particularly in animal models. His work has investigated the impact of methamphetamine on dopamine pathways in the brain, utilizing rat and mouse models. Newport's research has also explored the neurotoxic properties of peptides and other compounds, examining their effects on brain regions like the hippocampus. He has a publication record of 86 papers, with over 4,240 citations, and an h-index of 31. Newport has collaborated with researchers at the National Center for Toxicological Research, including Qiangen Wu and Syed F. Ali, on multiple shared publications. His recent publications include retraction notices for work on Aβ25–35 peptide and quinolinic acid.
Metrics
- h-index: 31
- Publications: 86
- Citations: 4,249
Selected Publications
-
Retraction notice to “On the in vivo early toxic properties of Aβ25–35 peptide in the rat hippocampus: Involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression” [Neurotoxicology and Teratology 33 (2011) 288–296] (2025)
-
Retraction notice to “On the early toxic effect of quinolinic acid: Involvement of RAGE” [Neurosci. Lett. 474(2) (2010) 74–78] (2024)
Collaboration Network
Top Collaborators
Elvis Cuevas
2 shared publications
- Retraction notice to “On the early toxic effect of quinolinic acid: Involvement of RAGE” [Neurosci. Lett. 474(2) (2010) 74–78]
- Retraction notice to “On the in vivo early toxic properties of Aβ25–35 peptide in the rat hippocampus: Involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression” [Neurotoxicology and Teratology 33 (2011) 288–296]
Susan M. Lantz
National Center for Toxicological Research
2 shared publications
In database
- Retraction notice to “On the early toxic effect of quinolinic acid: Involvement of RAGE” [Neurosci. Lett. 474(2) (2010) 74–78]
- Retraction notice to “On the in vivo early toxic properties of Aβ25–35 peptide in the rat hippocampus: Involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression” [Neurotoxicology and Teratology 33 (2011) 288–296]
Qiangen Wu
National Center for Toxicological Research
2 shared publications
In database
- Retraction notice to “On the early toxic effect of quinolinic acid: Involvement of RAGE” [Neurosci. Lett. 474(2) (2010) 74–78]
- Retraction notice to “On the in vivo early toxic properties of Aβ25–35 peptide in the rat hippocampus: Involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression” [Neurotoxicology and Teratology 33 (2011) 288–296]
Julio C. Tobón-Velasco
Instituto Nacional de Neurología y Neurocirugía (MX)
2 shared publications
- Retraction notice to “On the early toxic effect of quinolinic acid: Involvement of RAGE” [Neurosci. Lett. 474(2) (2010) 74–78]
- Retraction notice to “On the in vivo early toxic properties of Aβ25–35 peptide in the rat hippocampus: Involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression” [Neurotoxicology and Teratology 33 (2011) 288–296]
Syed F. Ali
National Center for Toxicological Research
2 shared publications
In database
- Retraction notice to “On the early toxic effect of quinolinic acid: Involvement of RAGE” [Neurosci. Lett. 474(2) (2010) 74–78]
- Retraction notice to “On the in vivo early toxic properties of Aβ25–35 peptide in the rat hippocampus: Involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression” [Neurotoxicology and Teratology 33 (2011) 288–296]
Abel Santamarı́a
2 shared publications
- Retraction notice to “On the early toxic effect of quinolinic acid: Involvement of RAGE” [Neurosci. Lett. 474(2) (2010) 74–78]
- Retraction notice to “On the in vivo early toxic properties of Aβ25–35 peptide in the rat hippocampus: Involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression” [Neurotoxicology and Teratology 33 (2011) 288–296]
Becky Divine
National Center for Toxicological Research
1 shared publication
In database
- Retraction notice to “On the early toxic effect of quinolinic acid: Involvement of RAGE” [Neurosci. Lett. 474(2) (2010) 74–78]
Merle G. Paule
National Center for Toxicological Research
1 shared publication
In database
- Retraction notice to “On the early toxic effect of quinolinic acid: Involvement of RAGE” [Neurosci. Lett. 474(2) (2010) 74–78]
Ashraf Virmani
Sigma Tau (Italy) (IT)
1 shared publication
- Retraction notice to “On the in vivo early toxic properties of Aβ25–35 peptide in the rat hippocampus: Involvement of the Receptor-for-Advanced Glycation-End-Products and changes in gene expression” [Neurotoxicology and Teratology 33 (2011) 288–296]
Similar Researchers
Based on overlapping research topics
John P. Culver
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes
Jai Shankar K. Yadlapalli
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Animal Behavior and Welfare Studies
Justin R. Nickell
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes
James Greenhaw
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Substance Abuse Treatment and Outcomes
Animal Behavior and Welfare Studies
Dylan R. Patel
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes
Scott M. Apana
University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies
Neuroscience and Neuropharmacology Research
Substance Abuse Treatment and Outcomes